Evidence map›Paper›PMID 39113803›Full record

ArticleTheranostics2024

Biomimetic nanoparticles with enhanced rapamycin delivery for autism spectrum disorder treatment via autophagy activation and oxidative stress modulation.

Chenlin Miao, Yizhe Shen, Yue Lang, Hui Li, Yan Gong, Yamei Liu, Huafei Li, Byron C Jones, Fuxue Chen, Shini Feng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chenlin MiaoSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Yizhe ShenSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Yue LangSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Hui LiSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Yan GongSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Yamei LiuSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Huafei LiSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Byron C JonesDepartment of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, USA.
Fuxue ChenSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.
Shini FengSchool of Lifesciences, Shanghai University, 333 Nanchen Road, 200444, Shanghai, P.R.C.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autism Spectrum DisorderAutophagyBlood-Brain BarrierNanoparticlesOxidative StressSirolimusAnimalsBiomimetic MaterialsBiomimeticsBrainDisease Models, AnimalDrug Delivery SystemsHumansMaleMicePeptidesPeptidesReactive Oxygen SpeciesSirolimusValproic AcidAutism spectrum disorderAutophagyBlood-brain barrierOxidative stressRapamycin

Identifiers

PMID39113803
PMCPMC11303075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.